investordatabase.org

Maxceed Capital

maxceed.co Direct investor

Maxceed Capital is a Taipei-based multi-family office established in 2018 with a $36M fund. It makes early-stage equity investments of $0.5–1.5M per venture, often co-investing, with a focus on South-East Asia and sectors including bio-medical and fintech.

Maxceed Capital is a family office headquartered in Taipei, Taiwan, founded in 2018. It invests directly in companies, at seed, in Bio-medical, reproductive, vision and medical Device. Its stated cheque size is Opening investment of 0.5 to $1.5 million per venture. $36 M USD under management and 3 portfolio companies, as it reports.

“Our investment partners focus on South-East Asia companies and all sorts of equity investments.”

— Maxceed Capital, own website
Layer
Direct investor
Type
Family office
Stage
Seed
Headquarters
Taipei, Taiwan
Invests in
South-East Asia
Sectors
Bio-medical, Reproductive, Vision, Medical Device, Fintech, Cyber Security, Fraud Prevention
Cheque size
Opening investment of 0.5 to $1.5 million per venture
Founded
2018
Assets under management
$36 M USD
Portfolio
3 companies

Team, as Maxceed Capital publishes it

  • Uchikata Junitsu General Partner
  • Gian Chen General Partner
  • Viviane Yik Manager
  • Billy Chen Legal Consultant (K&L Gates, Partner)
  • Dien Chang Certified Public Accountant (Deloitte, Partner)

Names and roles exactly as listed on maxceed.co. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page Maxceed Capital publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

  • https://www.maxceed.co/name, is_investor, layer, type, hq_country, hq_city, invests_in_geographies, stage_min, sectors, cheque_size, thesis_quote, description, founded, aum, portfolio_count, people, status

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 19089 · added 2026-10-26 · link last verified 2026-10-26 · confidence high

Similar investors

Listed under